Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
775.4 USD | -1.48% | +0.48% | +33.00% |
04:53pm | Eli Lilly: research collaboration with Totus Medicines | CF |
04:25pm | Eli Lilly: positive trials in type 2 diabetes | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.00% | 709B | |
+30.77% | 595B | |
-2.34% | 367B | |
+20.03% | 334B | |
+5.00% | 289B | |
+14.47% | 239B | |
+9.08% | 211B | |
-3.84% | 203B | |
+8.83% | 171B | |
-0.30% | 163B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company, Q3 2022 Earnings Call, Nov 01, 2022